Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Poland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20082
20102
20111
20133
20151
20224
20234
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Active, not recruiting5
Recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company3
Immunovant Sciences GmbH3
Viatris Innovation GmbH3
Bristol-Myers Squibb2
Takeda2
Amgen1
AstraZeneca1
Baxalta now part of Shire1
Diamyd Medical AB1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases22
Immune System Diseases12
Lupus Erythematosus, Systemic9
Connective Tissue Diseases7
Arthritis, Rheumatoid3
Joint Diseases3
Rheumatic Diseases3
Blood Platelet Disorders2
Cytopenia2
Graves Ophthalmopathy2

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.